(Q43796137)

26 November 2017

C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease (English)

1 reference

26 November 2017

0 references

7

1 reference

26 November 2017

Madsen T

1

1 reference

26 November 2017

Skou HA

2

1 reference

26 November 2017

Hansen VE

3

1 reference

26 November 2017

Fog L

4

1 reference

26 November 2017

Christensen JH

5

1 reference

26 November 2017

Toft E

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Cardiology

26 November 2017

1 reference

26 November 2017

88

1 reference

26 November 2017

10

1 reference

26 November 2017

1139-1142

1 reference

Atherosclerosis — An Inflammatory Disease

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Dietary polyunsaturated fatty acids and inflammatory mediator production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Lipid mediators in inflammatory disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Fatty acid modulation of endothelial activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Dietary n-3 fatty acids and therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Lipid treatment of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n−3 polyunsaturated fatty acids: study design implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

Essential fatty acids in health and chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

n-3 fatty acids and acute-phase proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

n-3 fatty acids and leucocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902049-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(01)02049-5

1 reference

26 November 2017

1 reference